Clinical Trial Update: Circulating Tumour DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating adjuvant treatment decisions in stage II colon cancer using circulating tumour DNA to guide therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer

Snippet

Sponsor: Technische Universität Dresden | Conditions: Colon Cancer Stage II | Phase 3 | Status: RECRUITING